Cancer Discovery

Cancer Discovery

癌症发现

  • 1区 中科院分区
  • Q1 JCR分区

期刊简介

《Cancer Discovery》是由American Association for Cancer Research Inc.出版社于2011年创办的英文国际期刊(ISSN: 2159-8274,E-ISSN: 2159-8290),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为ONCOLOGY。作为SCIE收录期刊(JCR分区 Q1,中科院 1区),本刊采用OA未开放获取模式(OA占比0.0156...%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比90.60%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在117篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Cancer Discovery审稿周期约为 较慢,6-12周 。该刊近年未被列入国际预警名单,年发文量约117篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 117 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
ONCOLOGY 肿瘤学
1区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
ONCOLOGY 肿瘤学
1区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 8 / 322

97.7%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 7 / 322

97.98%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:22.9 SJR:7.533 SNIP:3.803
学科类别 分区 排名 百分位
大类:Medicine 小类:Oncology Q1 17 / 404

95%

期刊发文

  • Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma

    Author: Suresh, Shruthy; Rabbie, Roy; Garg, Manik; Lumaquin, Dianne; Huang, Ting -Hsiang; Montal, Emily; Ma, Yilun; Cruz, Nelly M.; Tang, Xinran; Nsengimana, Jeremie; Newton-Bishop, Julia; Hunter, Miranda V.; Zhu, Yuxin; Chen, Kevin; de Stanchina, Elisa; Adams, David J.; White, Richard M.

    Journal: CANCER DISCOVERY. 2023; Vol. 13, Issue 1, pp. 194-215. DOI: 10.1158/2159-8290.CD-22-0427

  • A Molecular Switch between Mammalian MLL Complexes Dictates Response to Menin-MLL Inhibition

    Author: Soto-Feliciano, Yadira M.; Sanchez-Rivera, Francisco J.; Perner, Florian; Barrows, Douglas W.; Kastenhuber, Edward R.; Ho, Yu-Jui; Carroll, Thomas; Xiong, Yijun; Anand, Disha; Soshnev, Alexey A.; Gates, Leah; Beytagh, Mary Clare; Cheon, David; Gu, Shengqing; Liu, X. Shirley; Krivtsov, Andrei, V; Meneses, Maximiliano; de Stanchina, Elisa; Stone, Richard M.; Armstrong, Scott A.; Lowe, Scott W.; Allis, C. David

    Journal: CANCER DISCOVERY. 2023; Vol. 13, Issue 1, pp. 146-169. DOI: 10.1158/2159-8290.CD-22-0416

  • OncoLoop: A Network-Based Precision Cancer Medicine Framework

    Author: Vasciaveo, Alessandro; Arriaga, Juan Martin; de Almeida, Francisca Nunes; Zou, Min; Douglass Jr, Eugene F.; Picech, Florencia; Shibata, Maho; Rodriguez-Calero, Antonio; de Brot, Simone; Mitrofanova, Antonina; Chua, Chee Wai; Karan, Charles; Realubit, Ronald; Pampou, Sergey; Kim, Jaime Y.; Afari, Stephanie N.; Mukhammadov, Timur; Zanella, Luca; Corey, Eva; Alvarez, Mariano J.; Rubin, Mark A.; Shen, Michael M.; Califano, Andrea; Abate-Shen, Cory

    Journal: CANCER DISCOVERY. 2023; Vol. 13, Issue 2, pp. 386-409. DOI: 10.1158/2159-8290.CD-22-0342

  • Discovery of Targets for Immune-Metabolic Antitumor Drugs Identifi es Estrogen-Related Receptor Alpha

    Author: Sahu, Avinash; Wang, Xiaoman; Munson, Phillip; Klomp, Jan P. G.; Wang, Xiaoqing; Gu, Shengqing Stan; Han, Ya; Qian, Gege; Nicol, Phillip; Zeng, Zexian; Wang, Chenfei; Tokheim, Collin; Zhang, Wubing; Fu, Jingxin; Wang, Jin; Nair, Nishanth Ulhas; Rens, Joost A. P.; Bourajjaj, Meriem; Jansen, Bas; Leenders, Inge; Lemmers, Jaap; Musters, Mark; van Zanten, Sanne; van Zelst, Laura; Worthington, Jenny; Lu, Jun S.; Juric, Dejan; Meyer, Clifford A.; Oubrie, Arthur; Liu, X. Shirley; Fisher, David E.; Flaherty, Keith T.

    Journal: CANCER DISCOVERY. 2023; Vol. 13, Issue 3, pp. 672-701. DOI: 10.1158/2159-8290.CD-22-0244

  • Targeting Microglial Metabolic Rewiring Synergizes with Immune-Checkpoint Blockade Therapy for Glioblastoma

    Author: Ye, Zengpanpan; Ai, Xiaolin; Yang, Kailin; Yang, Zhengnan; Fei, Fan; Liao, Xiaoling; Qiu, Zhixin; Gimple, Ryan C.; Yuan, Huairui; Huang, Hao; Gong, Yanqiu; Xiao, Chaoxin; Yue, Jing; Huang, Liang; Saulnier, Olivier; Wang, Wei; Zhang, Peidong; Dai, Lunzhi; Wang, Xin; Wang, Xiuxing; Ha Ahn, Young; You, Chao; Xu, Jianguo; Wan, Xiaoxiao; Taylor, Michael D.; Zhao, Linjie; Rich, Jeremy N.; Zhou, Shengtao

    Journal: CANCER DISCOVERY. 2023; Vol. 13, Issue 4, pp. 974-1001. DOI: 10.1158/2159-8290.CD-22-0455

  • Antibody-Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer

    Author: Weng, Weining; Meng, Tao; Zhao, Qianqian; Shen, Yi; Fu, Guoxiang; Shi, Jing; Zhang, Yue; Wang, Zhaohui; Wang, Mingqiao; Pan, Rong; Ma, Linjie; Chen, Caiwei; Wang, Lijun; Zhou, Biao; Zhang, Hui; Pu, Junyi; Zhang, Jianjian; Hu, Yi Peter; Hua, Guoqiang; Qian, Yu; Liu, Shu-Hui; Hu, Wenhao; Meng, Xun

    Journal: CANCER DISCOVERY. 2023; Vol. 13, Issue 4, pp. 950-973. DOI: 10.1158/2159-8290.CD-22-1368

  • Mutant and Wild-Type Isocitrate Dehydrogenase 1 Share Enhancing Mechanisms Involving Distinct Tyrosine Kinase Cascades in Cancer.

    Author: Chen D1,2, Xia S#1,2, Wang M#1,2,3, Lin R1,2, Li Y2,4, Mao H2,4, Aguiar M5, Famulare CA6, Shih AH6, Brennan CW6, Gao X1,2, Pan Y1,7, Liu S1,8, Fan J2,9, Jin L1,2, Song L10, Zhou A10, Mukherjee J11, Pieper RO11, Mishra A12, Peng J12, Arellano M1,2, Blum WG1,2, Lonial S1,2, Boggon TJ13, Levine RL14, Chen J#15,2.

    Journal: Cancer Discov. 2019 Mar 12. doi: 10.1158/2159-8290.CD-18-1040. [Epub ahead of print]

  • Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.

    Author: Wang G, Lu X, Dey P, Deng P, Wu CC, Jiang S, Fang Z, Zhao K, Konaparthi R, Hua S, Zhang J, Li-Ning-Tapia EM, Kapoor A, Wu CJ, Patel NB, Guo Z, Ramamoorthy V, Tieu TN, Heffernan T, Zhao D, Shang X, Khadka S, Hou P, Hu B, Jin EJ, Yao W, Pan X, Ding Z, Shi Y, Li L, Chang Q, Troncoso P, Logothetis CJ, McArthur MJ, Chin L, Wang YA, DePinho RA.

    Journal: Cancer Discov. 2016 Jan;6(1):80-95. doi: 10.1158/2159-8290.CD-15-0224. Epub 2015 Dec 23.